Fernández-Ruiz Javier, Gómez María, Hernández Mariluz, de Miguel Rosario, Ramos José A
Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University, Ciudad Universitaria s/n, 28040-Madrid, Spain.
Neurotox Res. 2004;6(5):389-401. doi: 10.1007/BF03033314.
Cannabis is the most commonly used illicit drug in western societies, in particular among young people. It is consumed even by women during pregnancy and lactation, which result in a variety of disturbances in the development of their offspring, because, like other habit-forming drugs, cannabinoids, the psychoactive ingredients of marijuana, can cross the placental barrier and be secreted in the maternal milk. Through this way, cannabinoids affect the ontogeny of various neurotransmitter systems leading to changes in different behavioral patterns. Dopamine and endogenous opioids are among the neurotransmitters that result more affected by perinatal cannabinoid exposure, which, when animals mature, produce changes in motor activity, drug-seeking behavior, nociception and other processes. These disturbances are likely originated by the capability of cannabinoids to influence the expression of key genes for both neurotransmitters, in particular, the enzyme tyrosine hydroxylase and the opioid precursor proenkephalin. In addition, cannabinoids seem to be also able to influence the expression of genes encoding for neuron-glia cell adhesion molecules, which supports a potential influence of cannabinoids on the processes of cell proliferation, neuronal migration or axonal elongation in which these proteins are involved. In support of this possibility, CB1 receptors, which represent the major targets for the action of cannabinoids, are abundantly expressed in certain brain regions, such as the subventricular areas, which have been involved in these processes during brain development. Finally, cannabinoids might also be involved in the apoptotic death that occurs during brain development, possibly by influencing the expression of Bcl-2/Bax system. Also in support of this option, CB1 receptors are transiently expressed during brain development in different group of neurons which do not contain these receptors in the adult brain. This paper will review all evidence relating cannabinoids to the expression of key genes for neural development, trying to establish the future research addressed to elucidate the mechanisms involved in the epigenetic action of cannabinoids during brain development.
大麻是西方社会最常用的非法药物,尤其是在年轻人中。甚至有孕妇和哺乳期妇女吸食大麻,这会导致其后代发育出现各种紊乱,因为大麻素(大麻的精神活性成分)像其他成瘾性药物一样,能够穿过胎盘屏障并分泌到母乳中。通过这种方式,大麻素会影响各种神经递质系统的个体发育,导致不同行为模式发生变化。多巴胺和内源性阿片类物质是围产期接触大麻素影响较大的神经递质,当动物成熟时,会导致运动活动、觅药行为、痛觉感受及其他过程发生变化。这些紊乱可能源于大麻素影响这两种神经递质关键基因表达的能力,特别是酪氨酸羟化酶和阿片肽前体脑啡肽原。此外,大麻素似乎还能够影响编码神经胶质细胞粘附分子的基因表达,这支持了大麻素对细胞增殖、神经元迁移或轴突伸长过程具有潜在影响的观点,而这些蛋白质参与了这些过程。为支持这一可能性,作为大麻素作用主要靶点的CB1受体,在某些脑区大量表达,如下脑室区域,该区域在大脑发育过程中参与了这些过程。最后,大麻素可能还参与大脑发育过程中发生的凋亡性死亡,可能是通过影响Bcl-2/Bax系统的表达。同样支持这一观点的是,CB1受体在大脑发育过程中在不同组神经元中短暂表达,但在成年大脑中这些神经元并不含有这些受体。本文将综述所有将大麻素与神经发育关键基因表达相关的证据,试图确定未来研究方向,以阐明大麻素在大脑发育过程中表观遗传作用所涉及的机制。